Track record · closed signal

UnitedHealth Group Incorporated (UNH) — closed signal from November 22, 2025

Partial Published before the outcome was known, scored automatically when the window closed on February 20, 2026.

Predicted vs. what happened

UNH price · publication thesis → realized outcomesplit-adjusted
$317.83 Published $382.01 Target $290.00 Window close $357.87 Peak
$310.81 – $320.67Entry zone — fair-value band
$317.83Published — price the day we called it
$382.01Target — the price the thesis aimed for
$357.87Peak — highest point inside the window, not a realized return
$290.00Window close — end-of-window price, context only

What happened

Partial

Reached 60% of the predicted growth at its peak, without hitting the target.

Peak price
$357.87
peak on January 23, 2026 — not a realized return
Peak gain
+12.6%
peak, from the publication price
Window close
$290.00
end-of-window price, context only
Days to target
Window
November 22, 2025 – February 20, 2026

The thesis — published November 22, 2025

Predicted growth
+21%
over the measurement window
Target price
$382.01
the price the thesis aimed for
Entry zone
$310.81 – $320.67
the fair-value band we waited for
Price at publication
$317.83
published November 22, 2025
Confidence
61%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

UnitedHealth is a large, well-known health company that has been under pressure because of regulatory talk and how its services are being used. Price action is mixed and a bit below its recent average, but investor feeling is very positive, which suggests big investors are adding slowly. With no fresh news, expect a cautious recovery over the next few months if policy uncertainty eases.

Primary drivers

  • Large, diversified health and insurance business with scale advantages.
  • Stock is settling after a pullback and shows signs of steady buying.
  • Investor sentiment is very strong despite weak near-term fundamentals.
  • Future policy and how services are used will swing performance.

How it played out

UNH: thesis partially played out, target not reached

Lyra published UNH at $317.83 on 2025-11-22, with expected growth of 21%. The thesis pointed to UnitedHealth's scale, a stock settling after a pullback, signs of steady buying, very strong investor sentiment, and policy uncertainty as a key swing factor.

Inside the window, UNH rose to a peak of $357.87 on 2026-01-23, a 12.6% gain. It stayed below the $382.01 target and never reached it. By 2026-02-20, it ended at $290. The thesis partly played out early, but the full target missed.

What happened during the window

On January 27, 2026, MarketWatch reported that UnitedHealth said it expected 2026 revenue to decline, with guidance above $439 billion. The same report said the company reported fourth-quarter revenue of $113.2 billion and a drop in fourth-quarter net earnings.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.